stockportfolio.pro
Stocks / INCY vs LH
INCY vs LH
Incyte Corporation and Labcorp Holdings Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Incyte Corporation (INCY) | Labcorp Holdings Inc. (LH) | |
|---|---|---|
| Market cap | $20.4B | $21.7B |
| Revenue (latest FY) | $5.14B | $13.95B |
| Net income (latest FY) | $1.29B | $876.50M |
| Revenue growth (5y CAGR) | 14.0% | -0.0% |
| Net margin | 25.0% | 6.3% |
| Return on equity | 24.9% | 10.2% |
| P/E ratio | 14.4 | 23.5 |
| Dividend yield | — | 1.1% |
| Profitable years (of last 10) | 8 | 10 |
| Positive free cash flow | — | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open INCY — free Open LH — freeFrequently asked questions
Which is bigger, INCY or LH?
Labcorp Holdings Inc. is larger by market capitalization — $21.7B versus $20.4B.
Which grows faster, INCY or LH?
Over the last five fiscal years, Incyte Corporation grew revenue faster — 14.0%/yr versus -0.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.